# FDA Warning Letter: RenatiLabs Inc.
> 2023-08-01 · Division of Biological Products Operations I · `ea154cd6067dcde8`
## Letter
- **Company:** RenatiLabs Inc.
- **Posted Date:** 2023-08-01
- **Letter Issue Date:** 2023-06-01
- **Issuing Office:** Division of Biological Products Operations I
## Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*